Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof
CA 2504867 C · Owner: Sakaguchi, Nobuo · Inventors: Sakaguchi, Nobuo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is an object of the present invention to provide a high affinity antibody effective , as a diagnostic or therapeutic for various diseases; a transgenic mammal for producing the , high affinity antibody; and a medicine comprising the high affinity antibody or a cell , producing the high affinity antibody. According to the present invention a , transgenic , mammal carrying a GANP gene transferred thereinto its progeny, or a part , thereof, and a method of producing a high affinity antibody using the same are provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 7, 2003 and granted February 5, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 7, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 7, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.